Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya

PLoS ONE

Volumn 12, Issue 9, 2017, Pages

  Temu, Tecla M ^a   Lane, Kathleen A ^b   Shen, Changyu ^c   Ng’ang’a, Loise ^d   Akwanalo, Constantine O ^e,f   Chen, Peng Sheng ^g   Emonyi, Wilfred ^e,f   Heckbert, Susan R ^h   Koech, Myra M ^e   Manji, Imran ^e,f   Vatta, Matteo ^g   Velazquez, Eric J ^d   Wessel, Jennifer ^g   Kimaiyo, Sylvester ^e,f,i   Inui, Thomas S ^f,g   Bloomfield, Gerald S ^d  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e MOI TEACHING AND REFERRAL HOSPITAL   (Kenya)

^f ACADEMIC MODEL PROVIDING ACCESS TO HEALTHCARE AMPATH   (Kenya)

^g INDIANA UNIVERSITY   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ MOI UNIVERSITY   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTENSION; KENYA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; VALVULAR ATRIAL FIBRILLATION; VALVULAR HEART DISEASE; YOUNG ADULT; ADOLESCENT; COMPLICATION;

ADOLESCENT; ADULT; AGED; ATRIAL FIBRILLATION; FEMALE; HEART VALVE DISEASES; HOSPITALIZATION; HUMANS; KENYA; MALE; MIDDLE AGED; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 85029861058     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0185204     Document Type: Article

References (23)

1. Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur. Heart J. 2013; 34:2746–2751. https://doi.org/10.1093/eurheartj/eht280 PMID: 23900699
2. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: A global burden of disease 2010 study. Circulation 2014; 129:837–847. https://doi.org/10.1161/CIRCULATIONAHA.113.005119 PMID: 24345399
3. Stewart S, Hart CL, Hole DJ, Mcmurray JJ. A Population-Based Study of the Long-term Risks Associated with Atrial Fibrillation: 20-Year Follow-up of the Renfrew / Paisley Study. Am. J. Med. 2002; 113:359–364. PMID: 12401529
4. Healey JS, Oldgren J, Ezekowitz M, Zhu J, Pais P, Wang J, et al. Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study. The Lancet 2016; 388:1161–9.
5. Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat. Rev. Cardiol. 2014; 11: 639–54 https://doi.org/10.1038/nrcardio.2014.118 PMID: 25113750
6. Alonso A, Agarwal SK, Soliman EZ, Ambrose M, Chamberlain AM, Prineas RJ, et al. Incidence of atrial fibrillation in whites and African-Americans: The Atherosclerosis Risk in Communities (ARIC) study. Am. Heart J. 2009; 158:111–117. https://doi.org/10.1016/j.ahj.2009.05.010 PMID: 19540400
7. Moran A, Forouzanfar M, Sampson U, Chugh S, Feigin V, Mensah G. The epidemiology of cardiovascular diseases in sub-saharan Africa: The global burden of diseases, injuries and risk factors 2010 study. Prog. Cardiovasc. Dis. 2013; 56:234–2398. https://doi.org/10.1016/j.pcad.2013.09.019 PMID: 24267430
8. Oldgren J, Healey JS, Ezekowitz M, Commerford P, Avezum A, Pais P, et al. Variations in Etiology and Management of Atrial Fibrillation in a Prospective Registry of 15,400 Emergency Department Patients in 46 Countries: The RE-LY AF Registry. Circulation 2014; 129:1568–76. https://doi.org/10.1161/CIRCULATIONAHA.113.005451 PMID: 24463370
9. Zühlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido B, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: The Global Rheumatic Heart Disease Registry (the REMEDY study). Eur. Heart J. 2015; 36:1115–1122. https://doi.org/10.1093/eurheartj/ehu449 PMID: 25425448
10. Zühlke L, Karthikeyan G, Engel ME, Rangarajan S, Mackie P, Mauff BC, et al. Clinical Outcomes in 3343 Children and Adults with Rheumatic Heart Disease from 14 Low and Middle Income Countries: 2-Year Follow-up of the Global Rheumatic Heart Disease Registry (the REMEDY study). Circulation 2016; 134:1456–1466. https://doi.org/10.1161/CIRCULATIONAHA.116.024769 PMID: 27702773
11. Bloomfield GS, Temu TM, Akwanalo CO, Chen PS, Emonyi W, Heckbert SR, et al. Genetic mutations in African patients with atrial fibrillation: Rationale and design of the Study of Genetics of Atrial Fibrillation in an African Population (SIGNAL). Am. Heart J. 2015; 170:455–464.e5. https://doi.org/10.1016/j.ahj.2015.06.008 PMID: 26385028
12. Engelgau MM, Sampson UK, Rabadan-Diehl C, Smith R, Miranda J, Bloomfield GS, et al. Tackling NCD in LMIC: achievements and lessons learned from the NHLBI–UnitedHealth Global Health Centers of Excellence Program. Global heart 2016; 11:5–15. https://doi.org/10.1016/j.gheart.2015.12.016 PMID: 27102018
13. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285:2864–2870. PMID: 11401607
14. Ntep-Gweth M, Zimmermann M, Meiltz A, Kingue S, Ndobo P, Urban P, et al. Atrial fibrillation in Africa: Clinical characteristics, prognosis, and adherence to guidelines in Cameroon. Europace 2010; 12:482–487. https://doi.org/10.1093/europace/euq006 PMID: 20179174
15. Zubaid M, Rashed WA, Alsheikh-Ali AA, AlMahmeed W, Shehab A, Sulaiman K, et al. Gulf survey of atrial fibrillation events (Gulf SAFE) design and baseline characteristics of patients with atrial fibrillation in the arab middle East. Circ. Cardiovasc. Qual. Outcomes 2011; 4:477–482. https://doi.org/10.1161/CIRCOUTCOMES.110.959700 PMID: 21772004
16. Sliwa K, Carrington MJ, Klug E, Opie L, Lee G, Ball J, et al. Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the Heart of Soweto Study. Heart 2010; 96:1878–82. https://doi.org/10.1136/hrt.2010.206938 PMID: 21062777
17. Shavadia J, Yonga G, Mwanzi S, Jinah A, Moriasi A, Otieno H. Clinical characteristics and outcomes of atrial fibrillation and flutter at the Aga Khan University Hospital, Nairobi. Cardiovasc. J. Afr. 2013; 24:6–9. https://doi.org/10.5830/CVJA-2012-064 PMID: 23612946
18. Prystowsky EN, Benson DW, Fuster V, Hart RG, Kay GN, Myeburg RJ, et al. Management of Patients With Atrial Fibrillation A Statement for Healthcare Professionals From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation 1996; 93:1262–77. PMID: 8653857
19. Kirley K, Qato DM, Kornfield R, Stafford RS, Caleb Alexander G. National trends in oral anticoagulant use in the United States, 2007 to 2011. Circ. Cardiovasc. Qual. Outcomes 2012; 5:615–621. https://doi.org/10.1161/CIRCOUTCOMES.112.967299 PMID: 22949490
20. Nieuwlaat R, Capucci A, Camm AJ, Camm AJ, Olsson SB, Andresen D, et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Hear. J 2005; 26:2422–2434.
21. Wen-Hang QI. Retrospective investigation of hospitalised patients with atrial fibrillation in mainland China. Int. J. Cardiol. 2005; 105:283–287 https://doi.org/10.1016/j.ijcard.2004.12.042 PMID: 16274769
22. Karthikeyan G, Zühlke L, Engel M, Rangarajan S, Yusuf S, Teo K,et al. Rationale and design of a Global Rheumatic Heart Disease Registry: The REMEDY study. Am. Heart J. 2012; 163.
23. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am. J. Cardiol. 1998; 82:2N–9N. PMID: 9809895